The idea that the liver may act as a filter of gastrointestinal tract bacteria that have entered the portal vein has long interested investigators. Although Schatten et al. (1953) reported a significant number of positive portal vein cultures, other workers (Coblentz et al., 1954; Taylor, 1956; Orloff et al., 1958) have reported very few posidive results and the general consensus has been that most of the recovered organisms were contaminants. These studies have usually been performed on blood samples taken under general anaesthesia, either during laparotomy or umbilical vein catheterisation (Dencker et al., 1974 Received for publication 26 April 1978 incidence of septicaemia and spontaneous bacterial peritonitis of presumed enteric origin (Conn, 1975) . Although this may be secondary to the impaired ability of the cirrhotic liver to kill bacteria (Rutenburg et al., 1959) , an additional possibility is that increased numbers of bacteria may be present in the portal vein. The presence of such bacteria might be important in the pathogenesis of liver disease, as the induction of experimental nutritional cirrhosis in rats can be delayed considerably by pre-feeding them with neomycin (Rutenburg et al., 1957) .
More recently, clinical and laboratory studies have suggested that the liver may act as a barrier to the passage of endotoxin from the gastrointestinal tract to the systemic circulation and that, after liver injury, this barrier may be ineffective (Ravin et al., 1960; Farrar and Corwin, 1966; Nolan 1975) . Studies in man have shown that systemic endotoxaemia correlates with the renal failure associated with acute hepatic failure (Wilkinson et al., 1974) . However, controlled studies of the presence of endotoxin or bacteria in the portal vein of patients with liver disease are lacking, largely because of the difficulty of obtaining blood samples.
A technique which gives easy and reliable access to the portal venous system in patients under local anaesthesia (Boyer et al., 1977) (Boyer et al., 1977) . Briefly, this was carried out under local anaesthesia in fully conscious patients by inserting a Chiba needle into the patient from a point in the mid-axillary line, just below the costophrenic angle toward the Ti1-12 interspace. The position of the needle was monitored by fluorocopy. Fifty per cent diatrizoate meglumine (Hypaque) was injected through the needle while it was withdrawn slowly through the liver substance. By this technique, entry into a blood vessel or bile duct could be readily identified by the character and direction of flow of the contrast material. Once blood could be easily aspirated, the needle was cleared of all contrast material and blood was withdrawn into a heparinised, disposable syringe. Ideally, 10 ml of blood was aspirated. Two millilitres was injected directly into an anaerobic culture tube. The remaining 8 ml was centrifuged and the plasma divided into two equal parts before being placed in separate endotoxin-free tubes. These tubes were coded and stored at -20°C.
Bile ducts of normal calibre were entered twice D. R. Triger, T. D. Boyer, and J. Levin and a normal gall bladder once during the study. In each case the needle was removed and a clean needle inserted along a different track. In all three cases, the portal blood which was subsequently aspirated was sterile.
Hepatic vein blood samples were obtained through a hepatic vein catheter and were processed similarly. A new catheter was used for each procedure. Initially, peripheral vein samples were obtained through an antecubital vein, using fully aseptic techniques. Early studies showed that samples obtained via the hepatic vein catheter were consistently endotoxin-free and, therefore, subsequent samples of peripheral venous blood were obtained at the end of each study, as the catheter was being removed.
Collection tubes, glass pipettes, and transhepatic needles were rendered endotoxin-free by heating at 180°C for three hours. Preliminary testing confirmed that the contrast material was endotoxin-free, and a 1:10 dilution of Hypaque did not prevent the detection of known concentrations of endotoxin with the Limulus assay.
BACTERIAL CULTURE Samples of portal vein, hepatic vein, and peripheral blood were collected in Anaport gassed-out tubes (Scott Laboratories, Fiskville, Rhode Island) and transported immediately to the microbiology laboratory. Conventional media for aerobic and anaerobic cultivation were inoculated from each specimen. The anaerobic plates for primary isolation (brain heart infusion blood agar and vitamin K-hemin solution blood agar) were incubated in a Gaspak jar (Baltimore Biological Laboratories, Cockeysville, Maryland) for 48 hours, before periodic examination over 14 days. Direct smears for gram stain also were obtained at the time of inoculation.
ENDOTOXIN
Endotoxin was detected with the Limulus amoebocyte lysate assay, as first described by Levin and Bang (1969) . All samples of plasma were extracted initially with chloroform for four hours to remove inhibitors. . 0 05 ml of the middle cloudy layer, which resulted after centrifugation of the emulsion of plasma and chloroform, was mixed with 0 05 ml of amoebocyte lysate, incubated at 37°C for four hours, and kept at room temperature for an additional 20 hours. The assay was read at hourly intervals during the initial four hours and the final reading was performed after 24 hours. Gelation, increased viscosity, or a definite increase in turbidity with flocculation were interpreted as positive reactions for endotoxin or endotoxin-like activity. Concurrent controls were performed with sterile, pyrogen-free 0 9 % NaCl (Cutter Laboratories, Berkeley, California) and were uniformly negative. (Table 1) . Seven of these were portal vein samples and in each case the hepatic vein and peripheral vein samples were negative for endotoxin. In one patient in whom anaerobic diphtheroids were cultured from the portal vein blood, the same blood sample also was strongly positive for endotoxin. In three patients, only the peripheral blood sample was endotoxin positive. In each case, the blood was taken through the hepatic vein catheter, the hepatic vein sample obtained by the same route being endotoxinnegative. In one patient, the hepatic vein sample was positive for endotoxin, while peripheral and portal vein samples were negative. Table 2 shows the frequency of endotoxin-positive samples according to major disease diagnoses. Endotoxin was detected in the portal venous blood of patients with both alcoholic and non-alcoholic liver disease with comparable frequency.
Discussion
This is the first systematic study of portal vein blood in fully conscious patients with liver disease. In common with earlier bacteriological studies of patients without liver disease, we encountered occasional cultures positive for diphtheroids, which we were inclined to dismiss as contaminants, although such organisms may be pathogenic and cause septicaemia (Jobanputra and Swain, 1975; Weiner and Werthamer, 1975; Gerry and Greenough, 1976) . The anaerobic diphtheroid cultured in case number 28 is of particular interest. The same blood sample was also strongly positive for endotoxin. It is noteworthy that injection of contrast material into the portal vein showed evidence of hepatofugal flow, a situation rarely encountered in hepatic cirrhosis. We cannot comment upon whether the association of this phenomenon with portal bacteraemia and endotoxaemia is more than coincidental. Although portal bacteraemia is unlikely to be a common event in liver disease, we cannot exclude the possibility that it occurs intermittently. Also, it may occur more frequently in patients with disease more advanced than those studied here.
In contrast, portal endotoxaemia appears to be relatively common ( (Bailey, 1976) , seven out of 15 (Prytz et al., 1976) , and 33 out of 34 (Jacob et al., 1977) . These apparent discrepancies may reflect differences in assay sensitivity, choice of subjects, or technique in obtaining samples. Prytz and colleagues (1976) , noting a similar frequency of Limulus positive samples in arterial blood of ambulant patients with liver disease to that in portal vein blood of peptic ulcer patients at surgery, inferred that cirrhotic livers lose the capacity to filter endotoxin. Our observation that none of seven patients with portal endotoxaemia had hepatic or peripheral vein endotoxin does not support this hypothesis.
The finding of peripheral vein endotoxaemia in three patients was unexpected. All three samples were obtained through the hepatic vein catheter while it was being withdrawn and, as all three hepatic vein samples were endotoxin-free, the possibility of contamination at the time of sampling is remote. Two patients had alcoholic hepatitis and fever and it is tempting to speculate that endotoxin was associated with the cause of the fever. However, seven other patients with alcoholic hepatitis and pyrexia were endotoxin-negative. The third patient had chronic active hepatitis and, although in remission and not receiving therapy at the time of the study, she relapsed three months later. It has been assumed that endotoxaemia associated with liver disease originates in the gastrointestinal tract (Caridis et al., 1972) but its occasional production elsewhere could account for isolated positive peripheral vein samples.
Contamination at the time of sampling could account for the positive samples obtained in this study. The extreme sensitivity of the Limulus test makes this a possibility, although every effort to avoid contamination was made. Skin contamination at the site of entry was minimised by thorough cleansing, and the same procedures were adopted in both the antecubital fossa and over the liver. Ability to reproduce the results with samples which were retested, in addition to validating the laboratory assay, is strong evidence against the positive results being due to contamination of the tubes. Furthermore, previous studies from our laboratory did not demonstrate endotoxaemia in normal persons .
Our technique depends upon the use of contrast material to identify the portal venous system, raising the possibility that the presence of Hypaque might affect the detection of endotoxin and bacteria. Although Hypaque is bactericidal to E. coli in vitro, in vivo studies in urine have not shown any effect in concentrations up to 25 % (Narins and Chase, 1971) .
The relatively low frequency of portal endotoxaemia does not exclude it as an important clinical entity, as it may occur only intermittently. In more severe liver disease, portal endotoxaemia may be more common, and may occur to such a degree that the liver is no longer able to filter endotoxin. Certain complications of liver disease are associated with systemic endotoxaemia, notably renal failure (Wilkinson et al., 1974) , ascites (Tarao et al., 1977) and consumption coagulopathy (Liehr et al., 1975) and are usually found with very advanced hepatic damage. The latter two complications contraindicate portal vein sampling by our technique but there were no clinical, biochemical or histological features to distinguish the patients with positive endotoxin tests (either peripheral or portal) from the others.
Our findings suggest that even the damaged liver can clear endotoxin from the circulation. Although this appears to contradict observations in experimental animals (Ravin et al., 1960; Greene et al., 1961; Farrar and Corwin, 1966) , such comparisons may not be valid because of the widely differing conditions for inducing endotoxaemia and liver damage.
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